Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Srijayaprakash B. Uppada"'
Autor:
Andrea Cercek, Michael R. Marco, Bryan C. Szeglin, Srijayaprakash B. Uppada, Jashodeep Datta, Peter Ntiamoah, Charles L. Sawyers, Jinru Shia, Punita Dhawan, Keisuke Kosumi, Julio Garcia-Aguilar, Jose G. Guillem, Jonathan N. Glickman, Garrett M. Nash, Afsar Barlas, Arthur E. Elghouayel, Martin R. Weiser, Karuna Ganesh, Chao Wu, Eran Sadot, Isaac Wasserman, Kentaro Inamura, Rona Yaeger, Leonard B. Saltz, J. Joshua Smith, Lik Hang Lee, Andrew T. Chan, Tsuyoshi Hamada, Katia Manova-Todorova, Xi Chen, Marios Giannakis, Shuji Ogino, Philip B. Paty, Reiko Nishihara, Nancy E. Kemeny
Publikováno v:
Clinical Cancer Research. 25:1948-1956
Purpose: SMAD4 has shown promise in identifying patients with colorectal cancer at high risk of recurrence or death. Experimental Design: A discovery cohort and independent validation cohort were classified by SMAD4 status. SMAD4 status and immune in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd6763010ee39254dbc2b2e723d33c5c
https://doi.org/10.1158/1078-0432.ccr-18-1726
https://doi.org/10.1158/1078-0432.ccr-18-1726
Autor:
Jason T Fong, Ryan J Jacobs, David N Moravec, Srijayaprakash B Uppada, Gregory M Botting, Marie Nlend, Neelu Puri
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e78398 (2013)
The use of tyrosine kinase inhibitors (TKIs) against EGFR/c-Met in non-small cell lung cancer (NSCLC) has been shown to be effective in increasing patient progression free survival (PFS), but their efficacy is limited due to the development of resist
Externí odkaz:
https://doaj.org/article/86457fa152f34fee92dd43a8e668c4b6
Autor:
Vijaya Raj Bhatt, Alison G. Freifeld, Lepakshi S. V. Madduri, Srijayaprakash B. Uppada, Siddappa N. Byrareddy, Brooke Lawson, Sravani Singu, Linda K. Bauer
Publikováno v:
Biotech Histochem
Pathologists collect swab samples for Papanicolaou (Pap) staining to diagnose various diseases including cancer and HIV. Time constraints and limited resources, may preclude staining a sample immediately. To re-confirm results, samples must be frozen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::507e8adc2572d68ece44e6b847928566
https://europepmc.org/articles/PMC7897329/
https://europepmc.org/articles/PMC7897329/
Publikováno v:
Experimental Cell Research. 349:119-127
Epithelial-mesenchymal transition (EMT) is an important mechanism in cancer progression and malignancy including colorectal cancer (CRC). Importantly, inflammatory mediators are critical constituents of the local tumor environment and an intimate lin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddd40ed29eae8541623797a4301b2dd1
https://doi.org/10.1016/j.yexcr.2016.10.005
https://doi.org/10.1016/j.yexcr.2016.10.005
Autor:
Chanjuan Shi, Srijayaprakash B. Uppada, Saiprasad Gowrikumar, Punita Dhawan, Mary Kay Washington, Rizwan Ahmad, Amar B. Singh
Publikováno v:
Oncogene
In IBD patients, integration between a hyper-activated immune system and epithelial cell plasticity underlies colon cancer development. However, molecular regulation of such a circuity remains undefined. Claudin-1 (Cld-1), a tight-junction integral p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d93ed66966bffecd40969bfe3c1c153d
https://pubmed.ncbi.nlm.nih.gov/31417178
https://pubmed.ncbi.nlm.nih.gov/31417178
Autor:
J. Joshua Smith, Bryan C. Szeglin, Amar B. Singh, Punita Dhawan, Rizwan Ahmad, Balawant Kumar, Srijayaprakash B. Uppada, Saiprasad Gowrikumar, Surinder K. Batra, Xi Chen
Publikováno v:
Molecular Cancer
Molecular Cancer, Vol 17, Iss 1, Pp 1-15 (2018)
Molecular Cancer, Vol 17, Iss 1, Pp 1-15 (2018)
Background Chemotherapeutic agents that modulate cell cycle checkpoints and/or tumor-specific pathways have shown immense promise in preclinical and clinical studies aimed at anti-cancer therapy. MASTL (Greatwall in Xenopus and Drosophila), a serine/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d6e6f3df4c9dd18b3ba2450923fe720
http://europepmc.org/articles/PMC6090950
http://europepmc.org/articles/PMC6090950
Autor:
Zechary Rios, Luke Wojdyla, Neelu Puri, Srijayaprakash B. Uppada, Caleb Shearrow, Amanda L Stone, Joseph T. Devito, Gregory M. Botting, Zachary Crees, Kymberly Harrington, Jennifer Girard
Publikováno v:
Current Pharmaceutical Design. 20:6422-6437
Cancer is a leading cause of death worldwide and an estimated 1 in 4 deaths in the United States is due to cancer. Despite recent advances in cancer treatment, adverse effects related to cancer therapy remain a limiting factor for many patients. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a01e2f19c9a60225266a7ef58ee29f56
https://doi.org/10.2174/1381612820666140630100702
https://doi.org/10.2174/1381612820666140630100702
Autor:
Ceyda Bertram, Jennifer Girard, Manohar Reddy Shambannagari, David N Moravec, Ryan J. Jacobs, Srijayaprakash B. Uppada, Neelu Puri, Gregory M. Botting, Deven Etnyre, Amanda L Stone, Jason T. Fong, Zachary Crees, Supriya Rajanna
Publikováno v:
Cancer Biology & Therapy
Numerous tyrosine kinase inhibitors (TKIs) targeting c-Met are currently in clinical trials for several cancers. Their efficacy is limited due to the development of resistance. The present study aims to elucidate this mechanism of c-Met TKI resistanc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b185f548ab294d593eca4ee68172dd66
https://doi.org/10.4161/cbt.29451
https://doi.org/10.4161/cbt.29451
Autor:
Chanjuan Shi, Mary Kay Washington, Saiprasad Gowrikumar, Amar B. Singh, Rizwan Ahmad, Punita Dhawan, Srijayaprakash B. Uppada
Publikováno v:
Oncogene. 38:6566-6566
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::816e83d2f431ddb249e83f271921b53b
https://doi.org/10.1038/s41388-019-0864-9
https://doi.org/10.1038/s41388-019-0864-9
Autor:
Neelu Puri, Kavin Arasi, Ryan T. Pitman, Ceyda Bertram, Zachary Crees, Richard E. Mulnix, Amanda L Stone, Allison Retzer, Jennifer Girard, Srijayaprakash B. Uppada
Publikováno v:
OncoTargets and therapy
Richard E Mulnix,1,* Ryan T Pitman,1 Allison Retzer,2 Ceyda Bertram,1 Kavin Arasi,2 Zachary Crees,2 Jennifer Girard,2 Srijayaprakash B Uppada,1 Amanda L Stone,1 Neelu Puri1,* 1Department of Biomedical Sciences, University of Illinois at Chicago, Rock
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93c26c39910a794be2b72adf2b11bb60
http://europepmc.org/articles/PMC3872271
http://europepmc.org/articles/PMC3872271